Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data

Dis Markers. 2020 Oct 13:2020:8824717. doi: 10.1155/2020/8824717. eCollection 2020.

Abstract

Background: With an enormous amount of research concerning kidney cancer being conducted, various treatments have been applied to its cure. However, high recurrence and metastasis rates continue to pose a threat to the survival of patients with kidney renal clear cell carcinoma (KIRC).

Methods: Data from The Cancer Genome Atlas were downloaded, and a series of analyses were performed, including differential analysis, Cox analysis, weighted gene coexpression network analysis, least absolute shrinkage and selection operator analysis, multivariate Cox analysis, survival analysis, and receiver operating characteristic curve and functional enrichment analysis.

Results: A total of 5,777 differentially expressed genes were identified from the differential analysis. The Cox analysis showed 1,853 significant genes (P < 0.01). Weighted gene coexpression network analysis revealed that 226 genes in the module were related to clinical parameters, including Tumor-Node-Metastasis (TNM) staging. Least absolute shrinkage and selection operator and multivariate Cox analyses suggested that four genes (CDKL2, LRFN1, STAT2, and SOWAHB) had a potential function in predicting the survival time of patients with KIRC. Survival analysis uncovered that a high risk of these four genes was associated with an unfavorable prognosis. Receiver operating characteristic curve analysis further confirmed the accuracy of the risk score model. The analysis of clinicopathological parameters of the four identified genes revealed that they were associated with the progression of KIRC.

Conclusion: The gene expression model consisting of CDKL2, LRFN1, STAT2, and SOWAHB is a promising tool for predicting the prognosis of patients with KIRC. The results of this study may provide insights into the diagnosis and treatment of KIRC.

MeSH terms

  • Aged
  • Biomarkers, Tumor / genetics
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / mortality*
  • Carcinoma, Renal Cell / pathology
  • Computational Biology / methods
  • Cyclin-Dependent Kinases / genetics
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Gene Regulatory Networks
  • Humans
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / mortality*
  • Kidney Neoplasms / pathology
  • Male
  • Membrane Glycoproteins / genetics
  • Middle Aged
  • Nerve Tissue Proteins / genetics
  • Prognosis
  • Proportional Hazards Models
  • STAT2 Transcription Factor / genetics

Substances

  • Biomarkers, Tumor
  • LRFN2 protein, human
  • Membrane Glycoproteins
  • Nerve Tissue Proteins
  • STAT2 Transcription Factor
  • STAT2 protein, human
  • CDKL2 protein, human
  • Cyclin-Dependent Kinases